EM2211F "Beta Cells and Immune Cells: Breaking the Cycle of Type 1 Diabetes" (IM GR-111822)
Purpose and Overview
The purpose of my talk is to discuss new findings concerning the relationship(s) between beta cells and immune cells that lead to autoimmune diabetes. I also plan to discuss new treatments for treatment/delay/prevention of Type 1 diabetes.
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Understand the natural history of Type 1 diabetes.
- Identify inflammatory pathways involved in beta cell destruction.
- Understand therapies that may change the course of Type 1 diabetes.
Kevan Herold, M.D.
C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)
Yale School of Medicine
Leonard L. Madison, M.D. Visiting Professor in Diabetes, Endocrinology and Metabolism
Available Credit
- 1.00 AMA
Price
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome